RESEARCH-USE BIOSIMILAR ANTIBODY
Ponezumab
Monoclonal antibody · IgG2
Ponezumab (PF-04360365; RN 1219) is a humanized anti-amyloid-β (Amyloid-β) IgG2 monoclonal antibody. Ponezumab reduces Aβ levels in the central nervous system and improves the performance of mice in various learning and memory models. Ponezumab is applicable to the research of Alzheimer's disease.
TARGETAPP
YMonoclonal antibody
CATALOGSC-BS-260
CATALOG NUMBERSC-BS-260
MOLECULAR WEIGHTApprox. 145.65 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Ponezumab (PF-04360365; RN 1219) is a humanized anti-amyloid-β (Amyloid-β) IgG2 monoclonal antibody. Ponezumab reduces Aβ levels in the central nervous system and improves the performance of mice in various learning and memory models. Ponezumab is applicable to the research of Alzheimer's disease.
Ponezumab is a recombinant research-use antibody directed against APP.